Tirzepatide: Clinical review of the “twincretin” injectable
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2023/04/18
-
Indian UGC (journal)
-
Refrences49
-
Citations2
-
Zach Krauss Cedarville University , Cedarville, OH , USA
-
Alexandra Hintz Cedarville University , Cedarville, OH , USA
-
Rebecca Fisk Trinity Health , Grand Rapids, MI , USA
Abstract
Cite
Krauss, Zach, et al. “Tirzepatide: Clinical Review of the ‘twincretin’ Injectable”. American Journal of Health-System Pharmacy, vol. 80, no. 14, 2023, pp. 879-88, https://doi.org/10.1093/ajhp/zxad080.
Krauss, Z., Hintz, A., & Fisk, R. (2023). Tirzepatide: Clinical review of the “twincretin” injectable. American Journal of Health-System Pharmacy, 80(14), 879-888. https://doi.org/10.1093/ajhp/zxad080
Krauss, Zach, Alexandra Hintz, and Rebecca Fisk. “Tirzepatide: Clinical Review of the ‘twincretin’ Injectable”. American Journal of Health-System Pharmacy 80, no. 14 (2023): 879-88. https://doi.org/10.1093/ajhp/zxad080.
1.
Krauss Z, Hintz A, Fisk R. Tirzepatide: Clinical review of the “twincretin” injectable. American Journal of Health-System Pharmacy. 2023;80(14):879-88.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- Factors Associated With Burnout Among US Hospital Clinical Pharmacy Practitioners: Results of a Nationwide Pilot Survey
- Prevention and Management of Antineoplastic Extravasation Injury
- Reduction in Surface Contamination with Cyclophosphamide in 30 US Hospital Pharmacies following Implementation of a Closed-System Drug Transfer Device
- Epidemiology of Clostridium difficile Infection
- Aminoglycoside-Induced Nephrotoxicity
Refrences
Refrences Analysis
The category
Medicine: Medicine (General) 37
is the most frequently represented among the references in this article. It primarily includes studies from New England Journal of Medicine and Diabetes Care. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Glucagon‐like peptide agonists: A prospective review | Endocrinology, Diabetes & Metabolism |
| 3 | 2023 |
| Tirzepatide-associated starvation ketoacidosis | Clinical Toxicology |
| 2023 |
Citations Analysis
| Category | Category Repetition |
|---|---|
| Medicine: Public aspects of medicine: Toxicology. Poisons | 1 |
The category
Medicine: Public aspects of medicine: Toxicology. Poisons 1
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Glucagon‐like peptide agonists: A prospective review and was published in 2023. The most recent citation comes from a 2023 study titled Glucagon‐like peptide agonists: A prospective review. This article reached its peak citation in 2023, with 2 citations. It has been cited in 2 different journals. Among related journals, the Endocrinology, Diabetes & Metabolism cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.